Antibody Engineering

Antibody engineering is a process used to alter the properties of antibodies to create molecules with improved therapeutic potential. This is done by modifying the antibodies’ structure, affinity and specificity in order to increase their effectiveness against a specific target or to modify their physiological properties. This technique is used to improve the effectiveness of treatments, to reduce the side effects of drugs, and to create new antibodies that can recognize and bind to antigenic targets. In addition, antibody engineering is being used to develop new vaccines and therapeutic antibodies that can provide better protection against diseases. The application of antibody engineering is growing in the fields of biotechnology, drug development, and medical diagnostics, as it allows for more targeted and efficient treatments.


From: International Journal of Antibiotic Research

Related Article For "Antibody Engineering"

About (8) results

Article:

Laryngeal Tissue Engineering using Rabbit Adipose Derived Stem Cells in Fibrin: A Pre-Clinical Model

Journal:

Otolaryngology Advances

Article:

Myasthenia and Antisynthetase Antibody Syndrome: A Case Report in Togo

Journal:

Neurological Research And Therapy

Article:

Efficacy of The Immunotargeting Therapeutic Antibody Trastuzumab in HER2-Positive Advanced Gastric Cancer: A Meta-Analysis

Journal:

International Journal of Inflammation Research

Article:

Calcium Orthophosphate (CaPO4) Scaffolds for Bone Tissue Engineering Applications

Journal:

Biotechnology and Biomedical Science

Article:

Isolation of Human Monoclonal scfv Antibody Specifically Recognizing the D2-5-Ht1a Heteromer.

Journal:

New Developments in Chemistry

Article:

Prevalence and Risk Factors of Metabolic Syndrome Among Teaching Staff of Engineering Colleges in Central India

Journal:

Preventive Medicine And Care

Article:

Generation of a Single-Domain Antibody against Isolated Escherichia Coli that Causes Camel-Calf Death

Journal:

Veterinary Healthcare

Article:

Challenger Treatment of Various Cancers with T Cells Engineering

Journal:

Lung Cancer Epidemiology